Takeda
takeda.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
News
FDA approves Takeda's first-in-class narcolepsy drug
Takeda's Orzeyful is designed to treat the disease itself, not just its symptoms, with the potential to significantly improve quality of life.
Read more
Report
Takeda's first-in-class narcolepsy drug claims FDA approval
Takeda's orexin agonist Orzeyful is the first drug approved in the US that can treat the "full range" of narcolepsy type 1 symptoms, says the FDA.
Read more
Report
Takeda approval ushers in new wave of sleep drugs
An FDA nod mostly clears the way for Orzeyful to enter, by Wall Street estimates, a multibillion-dollar market for drugs that boost
Read more
Report
Takeda's narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
Biotech and pharma companies are testing orexin receptor agonists in a wide range of neurologic conditions.
Read more
Report
Pro access
Upgrade to see all 15 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Growth
Hiring Momentum
28/100
Slowing
Open positions
0
0 opened / 0 closed in 30 days
Hiring Dynamics
0%